Genetic Testing Market to Reach USD 36.40 Billion by 2030 Amid Cancer Testing & APAC Surge

Mordor Intelligence has published a new report on the Genetic Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The Genetic Testing Market is projected to reach USD 21.79 billion in 2025, with expected expansion to USD 36.40 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 10.81 percent. Genetic testing encompasses a spectrum of diagnostics-ranging from inherited disease screening to predictive assessments for cancer, prenatal and newborn screening, and personalized pharmacogenomics. Its increasing adoption in clinical and consumer arenas highlights its growing role in proactive healthcare planning and early disease intervention.

Report Overview: https://www.mordorintelligence.com/industry-reports/global-genetic-testing-market-industry?utm_source=openpr

Key Trends

1. Cancer Testing Gains Traction
The cancer-focused segment of genetic testing is showing strong momentum. Tests for inherited mutations-such as PALB2, CHEK2, BRIP1, RAD51C, RAD51D-are becoming more common as individuals and providers use genetic risk profiles to guide preventive care .The rising incidence of cancer (e.g., approximately 2 million new cases expected in the US in 2024 versus 1.93 million in 2023) is driving demand for early detection tools Recent product launches like Nonacus's GALEAS Hereditary Plus (January 2024) underscore growing focus on hereditary cancer diagnostics.

2. Regional Growth in Asia-Pacific
While North America currently leads in market size, the Asia‐Pacific region is the fastest‐growing market, driven by increasing healthcare investments, government support, and rising awareness of genetic disorders .Rapid expansion of prenatal and newborn screening programs in developing countries, coupled with improved access to direct‐to‐consumer tests, fuels the region's projected surge.

3. North America's Sustained Leadership
North America remains the top regional market in 2025, supported by strong healthcare infrastructure, favorable regulation, and high prevalence of genetic conditions like sickle cell disease and various cancers.The US Food and Drug Administration's authorization of In Vitro Diagnostic (IVD) products, such as Invitae's hereditary cancer panel in September 2023, further enhances market stability

Market Segmentation

By Technology

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Microarray

Fluorescence In Situ Hybridization (FISH)

Sanger sequencing

Other molecular and cytogenetic technologies

By Application (Value)

Cancer Diagnosis & Prognosis

Cardiovascular Disease Diagnosis

Neurological Disorder Diagnosis

Ancestry & Wellness

Other Applications

By End User

Hospitals & clinics

Diagnostic laboratories

Academic & research institutes

Direct-to-consumer (DTC) companies

Other end‐user categories

By Geography

North America

Europe (Germany

Asia‐Pacific

South America

Middle East & Africa

Explore Our Full Library of Healthcare Research Industry Reports:

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

Market concentration is considered high, with several global and regional players actively developing and commercializing genetic testing solutions. Prominent companies include:

Abbott Laboratories - Broad in vitro diagnostics portfolio including molecular assays.

Danaher Corporation (Cepheid Inc.) - Renowned for rapid genetic test platforms.

Illumina Inc. - Leader in sequencing technologies underlying many diagnostic tests.

Bio‐Rad Laboratories - Developer of PCR-based genetic testing tools.

F. Hoffmann‐La Roche AG - Major supplier of oncology and prenatal genetic tests.

Companies are increasingly forming collaborations with public health systems. A notable example is the UK's NHS and UK government's joint £175 million investment in whole genome sequencing for newborns, underscoring the role of public-private partnerships.

For More information Visit: https://www.mordorintelligence.com/industry-reports/global-genetic-testing-market-industry/companies?utm_source=openpr

Conclusion

The Genetic Testing Market is poised for significant growth over the next five years. Its estimated size of USD 21.79 billion in 2025 reflects strong demand, while the projected climb to USD 36.40 billion by 2030 indicates advancing adoption. Growth is driven primarily by increasing awareness of genetic disease screening, particularly cancer diagnostics, and by emerging markets across Asia‐Pacific and other regions. With top players continuing to launch targeted test kits and governments investing in genomic screening infrastructures, the industry is well-positioned to enhance early detection, personalized treatment strategies, and broader healthcare outcomes. These positive trends lay a strong foundation for continued market expansion into 2030 and beyond.

Industry Related Reports

Asia-Pacific Genetic Testing Market: The Asia Pacific Genetic Testing Market report segments the industry into By Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, Other Types), By Disease (Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Thalassemia, Rare Diseases, Other Diseases), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-genetic-testing-market?utm_source=openpr

North America Genetic Testing Market : The North America Genetic Testing Market report segments the industry into By Type (Carrier Testing, Diagnostic Testing, Newborn Screening, and more), By Diseases (Alzheimer's Disease, Cancer, Cystic Fibrosis, and more), By Technology (Cytogenetic Testing, and more), and By Country (United States, and more).

Get More Insights: https://www.mordorintelligence.com/industry-reports/north-america-genetic-testing-market-industry?utm_source=openpr

Preimplantation Genetic Testing Market: The Preimplantation Genetic Testing Market report segments the industry into By Test Type (Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS)), By Product and Service (Instruments, Reagents and Consumables, Software and Services), By Application (HLA Typing, IVF Prognosis, and more), By End User (Hospitals and Diagnostic Labs, Maternity Centers and Fertility Clinics, Other End Users), and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/preimplantation-genetic-testing-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.